Radiation oncology firm Nucletron plans to highlight new radiotherapy offerings at the upcoming European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting in London, the company said.
Oncology firm Elekta plans to feature a work-in-progress radiofrequency identification (RFID) system at the upcoming European Society for Therapeutic Radiology and Oncology (ESTRO) in London, the company said.